Business Standard

May start vaccine exports by year end, India remains priority: Serum

Company says it never exported vaccines at the cost of the people of India

Adar Poonawalla, CEO of Serum Institute of India Ltd
Premium

Adar Poonawalla, CEO of Serum Institute of India Ltd. (Photo: Bloomberg)

Sohini Das Mumbai
The world’s largest vaccine maker Serum Institute of India (SII) which is making the AstraZeneca and Novavax vaccines for Covid-19 in India said that it may start supplies to the global Covid vaccine alliance Covax by the end of this year. In a statement the firm also noted that it continues to prioritise India and has never exported Covid vaccines at the ‘cost of the people in India’.

In a message posted on micro-blogging site Twitter, SII said that it has delivered more than 200 million doses, even though it received EUA two months after the US pharma companies. “If

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 18 2021 | 8:13 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com